NEWS & INSIGHTS

Explore our company news, white papers, and upcoming events.

News Insights

February 21, 2024

Application Note

Supporting nasal product R&D and clinical manufacturing at Renaissance Learn more about the Nasal Product space and how Renaissance is making an impact.

READ MORE READ MORE
Insights

October 19, 2022

A Case Study on Operational Improvement

Overview: The following case study is a collaboration with Renaissance Lakewood and Raven consulting on continuous...

READ MORE READ MORE
Insights

October 6, 2022

Nasal spray development: Formulation and device considerations

A look at the interconnected role of the formulation, formulation excipients, and nasal spray...

READ MORE READ MORE
Insights

September 20, 2022

Penetration enhancers and mucoadhesives in liquid nasal spray formulations

A review of nasal spray formulation excipients and their potential for enhancing drug delivery. Test

READ MORE READ MORE
Insights

August 22, 2022

Understanding the Basics of Sterile Manufacturing

When developing a sterile product, people often do not understand what’s required to manufacture the product....

READ MORE READ MORE
Insights

August 1, 2022

What is a CDMO?

A CDMO is a Contract Development and Manufacturing Organization that accelerates how pharmaceutical companies bring drugs and therapies to market. The drug discovery to market pipeline is filled with many challenges, partnering with a CDMO lowers the risk and capital investment associated with this multi-step, multi-year, and often multi-million-dollar process. 

READ MORE READ MORE
Insights

June 11, 2021

Nasal spray characterization and device testing

Nasal spray devices are used to deliver both locally and systemically acting pharmaceutical products,1 and are readily available in the marketplace in unit dose and metered multi-dose formats.

READ MORE READ MORE
Stay in Touch

Subscribe to our Newsletter

"*" indicates required fields

By entering your personal information, you confirm that you are at least 18 years of age or older.